Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Moore's Blog Update

It all depends on the outcome of the Moore/TPL ownership question. If Moore, as claimed, didn't assign his rights to TPL, PTSC/Moore are in a very strong position to renegotiate.

No matter what one thinks about TPL, they would appear to be a necessary component in licensing by virtue of the reverse-engineered catalog of chips that they hold, unless ownership of that catalog is not theirs. Did they do the work on behalf of PTSC/Moore, or on their own initiative?

Compromise solution or stall licensing for years until resolved?

.

.

Be well

Share
New Message
Please login to post a reply